Literature DB >> 15983348

Second World Congress on the Insulin Resistance Syndrome: mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy.

Zachary T Bloomgarden1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15983348     DOI： 10.2337/diacare.28.7.1821

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

Review 1.  Interplay between insulin resistance and estrogen deficiency as co- activators in carcinogenesis.

Authors:  Zsuzsanna Suba
Journal:  Pathol Oncol Res       Date:  2011-10-09       Impact factor: 3.201

2.  Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications.

Authors:  Zsuzsanna Suba
Journal:  Onco Targets Ther       Date:  2014-01-23       Impact factor: 4.147

Review 3.  Circulatory estrogen level protects against breast cancer in obese women.

Authors:  Zsuzsanna Suba
Journal:  Recent Pat Anticancer Drug Discov       Date:  2013-05       Impact factor: 4.169

4.  Gender-related hormonal risk factors for oral cancer.

Authors:  Zsuzsanna Suba
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 2.874

Review 5.  Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies.

Authors:  Zsuzsanna Suba
Journal:  Drug Des Devel Ther       Date:  2014-09-11       Impact factor: 4.162

Review 6.  Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols.

Authors:  Antonio Simone Laganà; Paola Rossetti; Massimo Buscema; Sandro La Vignera; Rosita Angela Condorelli; Giuseppe Gullo; Roberta Granese; Onofrio Triolo
Journal:  Int J Endocrinol       Date:  2016-08-04       Impact factor: 3.257
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.